Please login to the form below

Not currently logged in
Email:
Password:

alteplase

This page shows the latest alteplase news and features for those working in and with pharma, biotech and healthcare.

Biogen hands out $120m upfront for Remedy stroke drug

Biogen hands out $120m upfront for Remedy stroke drug

The US biotech major is paying $120m upfront for rights to the drug, which is vying to be the first new treatment for ischaemic stroke since alteplase - still the only approved

Latest news

  • AZ's Brilinta disappoints in stroke trial AZ's Brilinta disappoints in stroke trial

    Currently the only drug approved for the treatment of ischemic stroke is Genentech's tissue plasminogen activator (tPA) Activase (alteplase), although this remains a controversial therapy as the drug has an

  • Daiichi Sankyo licenses clot-busting antibody Daiichi Sankyo licenses clot-busting antibody

    as Genentech/Boehringer Ingelheim's Activase/Actilyse (alteplase), but Translational Sciences believes there is significant room for improvement.

  • Lundbeck's desmoteplase flunks phase III stroke trial Lundbeck's desmoteplase flunks phase III stroke trial

    An older thrombolytic called alteplase (tPA) - sold by Genentech as Activase - is already approved to treat stroke, but remains a controversial therapy as the drug has an extremely narrow therapeutic window ... The drug is also easier to administer than

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics